OverviewSuggest Edit

ProciseDx is a company committed to the development and commercialization of point-of-care diagnostic tests. It helps GI physicians (gastroenterologists) and offers inflammatory and drug monitoring tests.
HQSan Diego, CA, US

Latest Updates

Employees (est.) (Nov 2021)24(-4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ProciseDx

Larry Mimms

Larry Mimms

Peter Westlake

Peter Westlake

President, CFO
Valerie Day

Valerie Day

VP, Product Development
David Booker

David Booker

Director, Automation & Instrumentation
Dan Kiser

Dan Kiser

VP, Quality & Regulatory
Kurt Bray

Kurt Bray

Director, Clinical Dev & Medical Affairs
Show more

ProciseDx Office Locations

ProciseDx has an office in San Diego
San Diego, CA, US (HQ)
9449 Carroll Park Dr
Show all (1)

ProciseDx Financials and Metrics

Summary Metrics

ProciseDx total Funding

$21.5 m

ProciseDx latest funding size

$13 m

Time since last funding

4 months ago

ProciseDx investors

ProciseDx's latest funding round in July 2021 was reported to be $13 m. In total, ProciseDx has raised $21.5 m
Show all financial metrics

ProciseDx Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

ProciseDx Online and Social Media Presence

Embed Graph

ProciseDx News and Updates

ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth

SAN DIEGO, July 13, 2021 /PRNewswire/ -- ProciseDx Inc. announces a $13 million convertible note financing to support international commercialization of the ProciseDx platform and US regulatory approval. Participants in the financing round included existing major shareholders (Nestlé...

ProciseDx Achieves CE Mark for Fecal Calprotectin Point of Care Testing

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system. Offering a point of care test for fecal calprotectin will help many physicians expedite...

ProciseDx Completes Distribution Agreements with D.I.D. in Italy and BHR in the United Kingdom

SAN DIEGO, Sept. 29, 2020 /PRNewswire/ -- ProciseDx Inc. has established distribution agreements with two new distributors in Europe: BHR Pharmaceuticals Ltd in the United Kingdom and D.I.D Diagnostic International Distribution S.p.A. in Italy. Both relationships will expand the sales...

ProciseDx Achieves CE Mark for Infliximab and Adalimumab Point of Care Testing

SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its infliximab (Procise IFX™) and adalimumab (Procise ADL™) point of care tests for use on the ProciseDx™ system. Previously, patients and physicians had to wait up to one week for...

ProciseDx Raises $10.5M in Series A Financing

ProciseDx Inc., a San Diego, CA-based Rapid Diagnostic Tests (TDRs) company, raised $10.5m in Series A funding. The round, which included $8.5m of equity and $2m of debt, was led by Biosynex, S.A., a French diagnostics company, which will now own 37% and will join the board. Nestlé Health Science, w…

ProciseDx Frequently Asked Questions

  • Who are ProciseDx key executives?

    ProciseDx's key executives are Larry Mimms, Peter Westlake and Valerie Day.

  • How many employees does ProciseDx have?

    ProciseDx has 24 employees.

  • Who are ProciseDx competitors?

    Competitors of ProciseDx include Imperative Care, Ellume and Cue.

  • Where is ProciseDx headquarters?

    ProciseDx headquarters is located at 9449 Carroll Park Dr, San Diego.

  • Where are ProciseDx offices?

    ProciseDx has an office in San Diego.

  • How many offices does ProciseDx have?

    ProciseDx has 1 office.